Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level

Vaccination against COVID-19 has occurred in Russia for more than two years. According to the Russian official clinical guidelines to maintain tense immunity in the conditions of the ongoing COVID-19 pandemic, it is necessary to use booster immunization six months after primary vaccination or a prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Godkov, Mikhail A., Ogarkova, Darya A., Gushchin, Vladimir A., Kleymenov, Denis A., Mazunina, Elena P., Bykonia, Evgeniia N., Pochtovyi, Andrei A., Shustov, Valeriy V., Shcheblyakov, Dmitry V., Komarov, Andrey G., Tsibin, Alexander N., Zlobin, Vladimir I., Logunov, Denis Y., Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861797/
https://www.ncbi.nlm.nih.gov/pubmed/36679936
http://dx.doi.org/10.3390/vaccines11010090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861797/
https://www.ncbi.nlm.nih.gov/pubmed/36679936
http://dx.doi.org/10.3390/vaccines11010090

Ejemplares similares